Latest News of DSGN
With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors
By Yahoo! Finance |
2 months ago
Institutions' significant holdings in Design Therapeutics (NASDAQ:DSGN) indicate control over its share price. Institutional investors, hedge funds, insiders, and private equity firms all play a role ...